Back to Journals » Clinical Audit » Volume 5
Clinical utility of antiemetics and complementary therapies in the prevention of postoperative nausea and vomiting
Authors Collins AS
Received 27 April 2013
Accepted for publication 20 June 2013
Published 21 August 2013 Volume 2013:5 Pages 67—76
DOI https://doi.org/10.2147/CA.S30588
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Angela S Collins
Capstone College of Nursing, University of Alabama, Tuscaloosa, AL, USA; Baptist Princeton, Birmingham, AL, USA
Abstract: Postoperative nausea and vomiting (PONV) is a persistent problem in perianesthesia practice. Approximately 30% of patients receiving anesthesia will experience this complication, which can increase patient dissatisfaction, increase costs, and in some patients precipitate other postoperative complications. During the last three decades, there has been increasing interest and research on best practices to diminish the incidence of this clinical problem, as patient satisfaction is linked to PONV guideline use. Some institutions have low incident rates because of consistent protocol use, and new medication classifications and multiple complementary therapies have been incorporated into daily use. There are several clinically useful guidelines and algorithms used to guide primary prevention strategies, as discussed in this review. However, severe PONV continues to be refractory to available interventions, and the best hope for elimination of this complication may arise from pharmacogenomics.
Keywords: postoperative nausea and vomiting, postanesthesia complications, clinical practice guidelines, pharmacology
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.